Cargando…
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis
We analyzed clinical outcome of patients with an isolated central nervous system lymphoma (CNSL) relapse after systemic non-Hodgkin’s lymphoma (NHL). All 23 patients with an isolated secondary CNSL (SCNSL) treated at two institutions from 04/2003–12/2007 were included into this analysis. At cerebral...
Autores principales: | Patrij, Katrin, Reiser, Marcel, Wätzel, Luise, Pels, Hendrik, Kowoll, Annika, Herrlinger, Ulrich, Engert, Andreas, Linnebank, Michael, Schackert, Gabriele, Vogt-Schaden, Marlies, Egerer, Gerlinde, Lamprecht, Monika, Batchelor, Tracy T., Schlegel, Uwe, Schmidt-Wolf, Ingo G. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118693/ https://www.ncbi.nlm.nih.gov/pubmed/21698087 http://dx.doi.org/10.3205/000134 |
Ejemplares similares
-
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
por: Seidel, Sabine, et al.
Publicado: (2020) -
Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma
por: Linnebank, M, et al.
Publicado: (2012) -
Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL
por: MITOBE, Yuta, et al.
Publicado: (2023) -
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma
por: Linnebank, M, et al.
Publicado: (2004) -
IL-5 Targeted Therapies for Nervous System Tumors – Progress, Pitfalls, and Prospects
por: Batchelor, Tracy
Publicado: (2022)